Europe Biomaterials Market Forecast 2022-2030

Europe Biomaterials Market Forecast 2022-2030

KEY FINDINGS

The Europe biomaterials market is estimated to rise with a CAGR of 12.62% during the forecast period, 2022-2030. The market growth is expected to be driven by technological transformations and changing healthcare ecosystems with the adoption of advanced and effective technologies.

MARKET INSIGHTS

The Europe biomaterials market growth evaluation entails the assessment of Italy, Russia, United Kingdom, Belgium, France, Poland, Germany, and Rest of Europe. In France, various organizations focus on researching biomaterial implants and tissue engineering. Moreover, the increasing geriatric population, the surge in prevalence of chronic diseases, and the presence of various research organizations are found to increase the demand for biomaterials in the region.

Furthermore, the Italy biomaterials market growth is stimulated by increasing demand from orthopedic, cardiovascular, ophthalmology, wound healing, dental, plastic surgery, tissue engineering, and neurological & central nervous system. However, the regional market lacks the presence of key players. But with increased funding and the rising interest in adopting cosmetic procedures, the biomaterials market is expected to grow in Italy.

In addition, Russia represents a very attractive market for developing biomaterials, given its extensive renewable energy assets and country-wide range of consumers. Major players operating in Russia are banking upon aggressive marketing and innovations strategies to cater to a wide range of consumers operating in the region. The improved socio-economic conditions and the modernization of consumption patterns in Russia are also anticipated to propel the demand for biomaterials in the country.

COMPETITIVE INSIGHTS

Some prominent market players in the market include Noble Biomaterials Inc, Royal DSM, BASF, Mitsubishi Chemical Holdings Corporation, Covestro AG, Collagen Solutions PLC, Zimmer Biomet Holdings Inc, etc.

Our report offerings include:
Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments


1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Key Drivers
3.1.1. Usage Of Biomaterials In Bone Fixation And Plastic Surgeries
3.1.2. Prevalence Of Geriatric Population And Cardiovascular Diseases
3.1.3. Government Support For Research And Development Initiatives
3.1.4. Applications Of Biomaterials In Plastic Surgeries And Wound Healing Therapies
3.2. Key Restraints
3.2.1. Biocompatibility Issues Associated With Biomaterial
3.2.2. Stringent Regulations
3.2.3. High Price Of The Implantable Biomaterials
4. Key Analytics
4.1. Impact Of Covid-19 On Biomaterials Market
4.2. Key Market Trends
4.3. Porter’s Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Value Chain Analysis
5. Market By Product
5.1. Metal-based Biomaterials
5.1.1. Stainless Steel
5.1.2. Titanium And Titanium Alloys
5.1.3. Co-cr Alloys
5.1.4. Magnesium
5.1.5. Gold
5.1.6. Silver
5.1.7. Nitinol
5.1.8. Other Metal-based Biomaterials
5.2. Polymer-based Biomaterials
5.2.1. Pmma
5.2.2. Polyethylene Terephthalate
5.2.3. Polyester
5.2.4. Polyvinylchloride
5.2.5. Silicone Rubber
5.2.6. Nylon
5.2.7. Polyetheretherketone
5.2.8. Other Polymer-based Biomaterials
5.3. Ceramic-based Biomaterials
5.3.1. Calcium Phosphate
5.3.2. Aluminum Oxide
5.3.3. Calcium Sulfate
5.3.4. Zirconia
5.3.5. Carbon
5.3.6. Glass
5.4. Natural Biomaterials
5.4.1. Hyaluronic Acid
5.4.2. Fibrin
5.4.3. Collagen & Gelatin
5.4.4. Cellulose
5.4.5. Chitin
5.4.6. Alginates
5.4.7. Silk
5.5. Inorganic Glass-based Biomaterials
5.6. Radiopaque Biomaterials
5.7. Regenerative Biomaterials
5.8. Hybrid Biomaterial Combinations
6. Market By Application
6.1. Cardiovascular
6.1.1. Catheters
6.1.2. Stents
6.1.3. Heart Valves
6.1.4. Pacemakers
6.1.5. Implantable Cardiac Defibrillators
6.1.6. Vascular Grafts
6.1.7. Guidewires
6.1.8. Sensors
6.2. Orthopedic
6.2.1. Joint Replacement
6.2.2. Fracture Fixation
6.2.3. Spine Adjustments
6.2.4. Orthobiology
6.2.5. Viscosupplementation
6.2.6. Bioresorbable Tissue Fixation
6.3. Ophthalmology
6.3.1. Contact Lenses
6.3.2. Intraocular Lenses
6.3.3. Functional Replacement Of Ocular Tissues
6.3.4. Synthetic Corneas
6.3.5. Other Ophthalmology Applications
6.4. Dental
6.4.1. Dental Bone Grafts And Substitutes
6.4.2. Dental Membranes
6.5. Wound Healing
6.5.1. Staples
6.5.2. Wound Closure Devices
6.5.3. Sutures
6.5.4. Hernia Meshes
6.5.5. Surgical Haemostats
6.5.6. Internal Tissue Sealants
6.5.7. Adhesion Barriers
6.6. Plastic Surgeries
6.6.1. Craniofacial Surgeries
6.6.2. Soft-tissue Fillers
6.7. Neurological/Central Nervous System
6.7.1. Shunting Systems
6.7.2. Neural Stem Cell Encapsulation
6.7.3. Cortical Neural Prosthetics (Cnp)
6.7.4. Hydrogel Scaffolds
6.8. Tissue Engineering
6.8.1. Tailoring Of Inorganic Nanoparticles
6.8.2. Scaffolds For Regenerative Medicines
6.8.3. Nanomaterial For Biosensing
6.9. Other Applications
6.9.1. Urinary Applications
6.9.2. Drug Delivery Systems
6.9.3. Bariatric Surgeries
6.9.4. Gastrointestinal Applications
7. Geographical Analysis
7.1. Europe
7.1.1. Market Size & Estimates
7.1.2. Key Growth Enablers
7.1.3. Key Challenges
7.1.4. Key Players
7.1.5. Country Analysis
7.1.5.1. United Kingdom
7.1.5.2. Germany
7.1.5.3. France
7.1.5.4. Italy
7.1.5.5. Russia
7.1.5.6. Belgium
7.1.5.7. Poland
7.1.5.8. Rest Of Europe
8. Competitive Landscape
8.1. Key Strategic Developments
8.1.1. Mergers & Acquisitions
8.1.2. Product Launches & Developments
8.1.3. Partnerships & Agreements
8.1.4. Business Expansions & Divestitures
8.2. Company Profiles
8.2.1. Basf
8.2.2. Bbs-bioactive Bone Substitutes
8.2.3. Bioretec Ltd
8.2.4. Carpenter Technology Corporation
8.2.5. Celanese Corporation
8.2.6. Collagen Solutions Plc
8.2.7. Corbion Nv
8.2.8. Covestro Ag
8.2.9. Dentsply Sirona
8.2.10. Evonik Industries
8.2.11. Mitsubishi Chemical Holdings Corporation
8.2.12. Noble Biomaterials Inc
8.2.13. Royal Dsm
8.2.14. Victrex Plc
8.2.15. Wright Medical Group Nv
8.2.16. Zimmer Biomet Holdings Inc

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings